Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • News

Rani Therapeutics To Present Data On Oral Delivery Of An Ustekinumab Biosimilar Via The RaniPill Capsule At Digestive Disease Week 2024

By Benzinga Newsdesk
May 9, 9:00 AM
Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present clinical

RANI

Read More
1 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Avi Kapoor
April 18, 9:03 AM
U.S. stock futures were higher this morning, with the Dow futures gaining over 50 points on Thursday.

BOH

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Avi Kapoor
April 17, 1:36 PM
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

ADPT

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights
April 17, 12:31 PM
Gainers INVO Bioscience (NASDAQ:INVO) stock rose 275.0% to $2.85 during Wednesday’s regular session. The market value of their…

ADIL

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights
April 12, 12:31 PM
Gainers PaxMedica (NASDAQ:PXMD) stock increased by 110.9% to $0.87 during Friday’s regular session. The company’s market cap stands…

ADIL

Read More
2 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Trading Ideas

Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday

By Avi Kapoor
March 27, 8:40 AM
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

BERY

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights
February 5, 9:06 AM
Gainers 4D Molecular Therapeutics (NASDAQ:FDMT) stock rose 60.1% to $28.0 during Monday’s pre-market session. The market value of…

ADVM

Read More
2 minute read
  • Biotech
  • General
  • News

Rani Therapeutics Announces Preclinical Pharmacodynamic Data On Transenteric Delivery Of GLP-1 Incretin Triagonist

By Benzinga Newsdesk
December 14, 9:09 AM
- Transenteric delivery of incretin triagonist of GLP-1, GIP, glucagon receptors elicits rapid weight loss in animal study –- Preclinical data support the potential for the RaniPill platform to enable oral delivery of

RANI

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights
December 8, 1:31 PM
Gainers Intensity Therapeutics (NASDAQ:INTS) stock increased by 107.2% to $8.29 during Friday’s regular session. The company’s market cap…

ALLR

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
December 6, 5:31 PM
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 17.9% to $0.31 during Wednesday’s after-market session. The market value…

APDN

Posts pagination

1 2 … 5 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service